In 2018, the global Prenatal and Newborn Genetic Testing market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

This report focuses on the global Prenatal and Newborn Genetic Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prenatal and Newborn Genetic Testing development in United States, Europe and China.

The key players covered in this study
Roche Diagnostic
Elitech Group
Myriad Genetics
Biocartis
IntegraGen
Perkin Elmer
WaferGen Biosystem
Interpace Diagnostics
Quest Diagnostic
Bio-Rad
AutoGenomics
Abbott
Cepheid
EKF Diagnostics
Natera
Agilent Technologies
Illumina
Ariosa Diagnostics
Sequenom

Market segment by Type, the product can be split into
Array-Comparative Genetic Hybridization (aCGH)
Fluorescence In-Situ Hybridization (FISH)
Polymerase Chain Reaction (PCR)

Market segment by Application, split into
Hospitals
Diagnostic Organization
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Prenatal and Newborn Genetic Testing status, future forecast, growth opportunity, key market and key players.
To present the Prenatal and Newborn Genetic Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Prenatal and Newborn Genetic Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.